Skip to main content

To learn more about the subject...

Articles about phage therapy and proofs of its efficacy

Housby, J.N., and Mann, N.H. (2009). Phage therapy. Drug discovery today 14, 536-540. Kropinski, A.M. (2006). Phage therapy everything old is new again. Can J Infect Dis Med Microbiol 17, 297-306.

Monk, A.B., Rees, C.D., Barrow, P., Hagens, S., and Harper, D.R. (2010). Bacteriophage applications: where are we now? Letters in applied microbiology 51, 363-369.

Smith, H.W., and Huggins, M.B. (1982). Successful treatment of experimental Escherichia coli infections in mice using phages: its general superiority over antibiotics. J Gen Microbiol 128, 307-318.

Smith, H.W., and Huggins, M.B. (1983). Effectiveness of phages treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129, 2659-2675.

Thiel, K. (2004). Old dogma, new tricks-21st century phage therapy. Nat Biotechnol 22, 31-36.

Articles about Staphylococcus pseudintermedius

Bannoehr, J., Ben Zakour, N.L., Waller, A.S., Guardabassi, L., Thoday, K.L., van den Broek, A.H., and Fitzgerald, J.R. (2007). Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J Bacteriol 189, 8685-8692.

Bannoehr, J., and Guardabassi, L. (2012). Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol 23, 253-266, e251-252.

Perreten, V., Kadlec, K., Schwarz, S., Gronlund Andersson, U., Finn, M., Greko, C., Moodley, A., Kania, S.A., Frank, L.A., Bemis, D.A., et al. (2010). Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 65, 1145-1154.